Citius Pharmaceuticals, Inc. Convertible Preferred Stock, Shares Reserved for Future Issuance
Citius Pharmaceuticals, Inc. (CTXR) had Convertible Preferred Stock, Shares Reserved for Future Issuance of 12.00 million shares as of 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance · last filed 2023-02-10
- 2022-12-31: Convertible Preferred Stock, Shares Reserved for Future Issuance 12.00M shares.
| Period end | Convertible Preferred Stock, Shares Reserved for Future Issuance |
|---|---|
| 2022-12-31 | 12.00M shares 10-Q · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |